Location History:
- San Diego, CA (US) (2017)
- Brisbane, CA (US) (2019 - 2024)
Company Filing History:
Years Active: 2017-2024
Title: Innovator Spotlight: Megan Dueck
Introduction
Megan Dueck is a prominent inventor based in Brisbane, California. She has made significant contributions to the field of nucleic acid analysis and quantification. With a total of seven patents to her name, her work is at the forefront of innovative technologies in molecular biology.
Latest Patents
Megan's latest patents include groundbreaking methods and systems for nucleic acid analysis and quantification. One of her notable inventions provides methods for amplifying and quantifying nucleic acids while detecting the presence or absence of a target in a sample. This technology utilizes a device with multiple partitions separated from the external environment by a gas-permeable barrier. The methods involve subjecting nucleic acid molecules to controlled heating within these partitions to generate data indicative of their melting points. Another significant patent is the microfluidic siphoning array for nucleic acid quantification, which involves isolating nucleic acid samples into microchambers, performing polymerase chain reactions, and analyzing the results.
Career Highlights
Megan Dueck has established herself as a leading figure in her field through her innovative research and development efforts. Her work at Combinati Incorporated has allowed her to push the boundaries of nucleic acid technology. She has consistently demonstrated her ability to create solutions that address complex challenges in molecular diagnostics.
Collaborations
Megan has collaborated with talented individuals such as Ju-Sung Hung and Andrew Zayac. These partnerships have further enhanced her research and contributed to the success of her projects.
Conclusion
Megan Dueck's contributions to the field of nucleic acid analysis and quantification are invaluable. Her innovative patents and collaborative efforts position her as a key player in advancing molecular biology technologies.